GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Rubius Therapeutics Inc (STU:5RT) » Definitions » Deferred Policy Acquisition Costs

Rubius Therapeutics (STU:5RT) Deferred Policy Acquisition Costs


View and export this data going back to 2019. Start your Free Trial

What is Rubius Therapeutics Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Rubius Therapeutics (STU:5RT) Business Description

Industry
Traded in Other Exchanges
N/A
Address
124 Washington Street, Suite 101, Foxborough, MA, USA, 02035
Rubius Therapeutics Inc develops red cell therapeutics (RCTs) for the treatment of patients with rare diseases, cancer, and autoimmune diseases.